These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 17075155)

  • 41. The potential role of trimethoprim-sulfamethoxazole in the treatment of drug-resistant tuberculosis.
    Palomino JC; Martin A
    Future Microbiol; 2016; 11(4):539-47. PubMed ID: 27070731
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Linezolid in children with drug resistant tuberculosis.
    Shah I; Dey A; Shetty NS
    Infect Dis (Lond); 2018; 50(11-12):868-870. PubMed ID: 30296864
    [No Abstract]   [Full Text] [Related]  

  • 43. Resistance patterns of multidrug-resistant tuberculosis in Western Province, Papua New Guinea.
    Simpson G; Coulter C; Weston J; Knight T; Carter R; Vincent S; Robertus L; Konstantinos A
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):551-2. PubMed ID: 21396218
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Fluoroquinolone and pyrazinamide resistance in multidrug-resistant tuberculosis.
    Pierre-Audigier C; Surcouf C; Cadet-Daniel V; Namouchi A; Heng S; Murray A; Guillard B; Gicquel B
    Int J Tuberc Lung Dis; 2012 Feb; 16(2):221-3, i-ii. PubMed ID: 22236923
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Back to the future: host-targeted chemotherapeutics for drug-resistant TB.
    Napier RJ; Shinnick TM; Kalman D
    Future Microbiol; 2012 Apr; 7(4):431-5. PubMed ID: 22439718
    [No Abstract]   [Full Text] [Related]  

  • 46. Infectious disease. Extensively drug-resistant TB gets foothold in South Africa.
    Cohen J
    Science; 2006 Sep; 313(5793):1554. PubMed ID: 16973846
    [No Abstract]   [Full Text] [Related]  

  • 47. Multidrug resistant tuberculosis in Ethiopian settings and its association with previous history of anti-tuberculosis treatment: a systematic review and meta-analysis.
    Eshetie S; Gizachew M; Dagnew M; Kumera G; Woldie H; Ambaw F; Tessema B; Moges F
    BMC Infect Dis; 2017 Mar; 17(1):219. PubMed ID: 28320336
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Second-line drug susceptibilities of multidrug-resistant tuberculosis strains isolated in Thailand: an update.
    Chaiprasert A; Srimuang S; Tingtoy N; Makhao N; Sirirudeeporn P; Tomnongdee N; Theankeaw O; Charoensook S; Leechawengwongs M; Prammananan T
    Int J Tuberc Lung Dis; 2014 Aug; 18(8):961-3. PubMed ID: 25199012
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Drug-resistance pattern of Mycobacterium tuberculosis strains from patients with pulmonary and extrapulmonary tuberculosis during 2006 to 2013 in a Korean tertiary medical center.
    Lee HY; Lee J; Lee YS; Kim MY; Lee HK; Lee YM; Shin JH; Ko Y
    Korean J Intern Med; 2015 May; 30(3):325-34. PubMed ID: 25995663
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Management of multidrug resistant tuberculosis.
    Daley CL; Caminero JA
    Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevalence and genetic determinant of drug-resistant tuberculosis among patients completing intensive phase of treatment in a Tertiary Referral Center in Nigeria.
    Mohammad AB; Iliyasu G; Habib AG
    Int J Mycobacteriol; 2017; 6(1):47-51. PubMed ID: 28317805
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Extrapulmonary tuberculosis: situation in the new century].
    García JF
    Enferm Infecc Microbiol Clin; 2008 Nov; 26(9):537-9. PubMed ID: 19100171
    [No Abstract]   [Full Text] [Related]  

  • 53. Drug-resistance patterns of Mycobacterium tuberculosis strains and associated risk factors among multi drug-resistant tuberculosis suspected patients from Ethiopia.
    Mesfin EA; Beyene D; Tesfaye A; Admasu A; Addise D; Amare M; Dagne B; Yaregal Z; Tesfaye E; Tessema B
    PLoS One; 2018; 13(6):e0197737. PubMed ID: 29864118
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Drug resistance among tuberculosis patients attending diagnostic and treatment centres in Makassar, Indonesia.
    Massi MN; Wahyuni S; Halik H; ; Yusuf I; Leong FJ; Dick T; Phyu S
    Int J Tuberc Lung Dis; 2011 Apr; 15(4):489-95. PubMed ID: 21396208
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drug-Resistant Tuberculosis: Challenges and Progress.
    Kurz SG; Furin JJ; Bark CM
    Infect Dis Clin North Am; 2016 Jun; 30(2):509-522. PubMed ID: 27208770
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen.
    Achar J; Berry C; Herboczek K; Parpieva N; Tillyashaykhov MN; Tigay ZN; Khamraev A; Velivela K; Seddon JA; du Cros P
    Emerg Infect Dis; 2015 Nov; 21(11):2105-6. PubMed ID: 26488556
    [No Abstract]   [Full Text] [Related]  

  • 58. Programmatic management of multidrug-resistant tuberculosis--15 years later.
    Nardell EA
    Int J Tuberc Lung Dis; 2011 Oct; 15(10):1280. PubMed ID: 22283883
    [No Abstract]   [Full Text] [Related]  

  • 59. Drug-resistant tuberculosis: what is to be done?
    Schluger NW
    Chest; 2009 Aug; 136(2):333-335. PubMed ID: 19666753
    [No Abstract]   [Full Text] [Related]  

  • 60. Resistance profile of drugs composing the "shorter" regimen for multidrug-resistant tuberculosis in Brazil, 2000-2015.
    Dalcolmo M; Gayoso R; Sotgiu G; D'Ambrosio L; Rocha JL; Borga L; Fandinho F; Braga JU; Arakaki Sanchez D; Dockhorn F; Centis R; Migliori GB
    Eur Respir J; 2017 Apr; 49(4):. PubMed ID: 28404651
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.